P
PUMA BIOTECHNOLOGY INCPBYI
Puma Biotechnology, Inc. is a biopharmaceutical company with a focus on the development and commercialization of innovative products to enhance cancer care. Puma in-licensed the global development and commercialization rights to PB272 (neratinib, oral) in.
US StocksHealthcareSmall CapBiotechnology
PBYI の価格トレンド
PUMA BIOTECHNOLOGY INC · TradingView フルチャート
NASDAQ:PBYI